Pieter A. Eichhorn

Bentley, WA, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Global analysis of cancer cell responses to USP9X inhibition.

Global analysis of cancer cell responses to USP9X inhibition.

Journal: The EMBO journal
Published: June 09, 2025

Influence of Epithelial-Mesenchymal Transition on Risk of Relapse and Outcome to Eribulin or Cyclin-Dependent Kinase Inhibitors in Metastatic Breast Cancer.

Influence of Epithelial-Mesenchymal Transition on Risk of Relapse and Outcome to Eribulin or Cyclin-Dependent Kinase Inhibitors in Metastatic Breast Cancer.

Journal: JCO precision oncology
Published: December 06, 2024

USP10/GSK3β-mediated inhibition of PTEN drives resistance to PI3K inhibitors in breast cancer.

USP10/GSK3β-mediated inhibition of PTEN drives resistance to PI3K inhibitors in breast cancer.

Journal: The Journal of clinical investigation
Published: March 27, 2024

Deubiquitinases in cancer.

Deubiquitinases in cancer.

Journal: Nature reviews. Cancer
Published: September 21, 2023

SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition.

SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition.

Journal: NPJ precision oncology
Published: July 20, 2023

TGF-β, EMT, and resistance to anti-cancer treatment.

TGF-β, EMT, and resistance to anti-cancer treatment.

Journal: Seminars in cancer biology
Published: July 13, 2022

Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity.

Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity.

Journal: Cancers
Published: February 02, 2021

OTUD4 enhances TGFβ signalling through regulation of the TGFβ receptor complex.

OTUD4 enhances TGFβ signalling through regulation of the TGFβ receptor complex.

Journal: Scientific reports
Published: February 03, 2020

USP26 regulates TGF-β signaling by deubiquitinating and stabilizing SMAD7.

USP26 regulates TGF-β signaling by deubiquitinating and stabilizing SMAD7.

Journal: EMBO reports
Published: January 08, 2020

Response to: USP26 regulates TGF-β signalling by deubiquitinating and stabilizing SMAD7; not applicable in glioblastoma.

Response to: USP26 regulates TGF-β signalling by deubiquitinating and stabilizing SMAD7; not applicable in glioblastoma.

Journal: EMBO reports
Published: December 21, 2019

Author Correction: c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression.

Author Correction: c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression.

Journal: Nature communications
Published: November 10, 2019

Adaptive Responses as Mechanisms of Resistance to BRAF Inhibitors in Melanoma.

Adaptive Responses as Mechanisms of Resistance to BRAF Inhibitors in Melanoma.

Journal: Cancers
Published: July 02, 2019
Showing 1-12 of 25

Last Updated: 09/26/2026